Holder snapshot 7 signals
Share change
+11,585,758
Put/Call ratio
204%
SEC-reported price per share
$16.89
Number of holders
118
Value change
+$203,068,084
Number of buys
70
Open additional details 1 more signal available
Number of sells
55
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
98,762,388

Security key

05337M104

Report period

Q1 2024

Institutions

118

Top holders

10

Ownership snapshot

Top reported holders of AVDL - Avadel Pharmaceuticals plc - American Depositary Shares, each representing one Ordinary Share, nominal value $0.01 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Janus Henderson Group Ltd.
Disclosed value leader
Janus Henderson Group Ltd.
Comparable rows
15/15
Latest evidence
31 Dec 2023
13F Lead comparable stake: 11% Showing 1-6 of 15 holder rows.

Quick read

Janus Henderson Group Ltd. leads the comparable SEC ownership view at 11%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Janus Henderson Group Ltd.'s linked filing trail.
Comparable ownership Top 5
Janus Henderson Group Ltd. 11%
RTW INVESTMENTS, LP 7%
Polar Capital Holdings Plc 6.8%
Jeffrey L. Gendell 5.7%
Vivo Capital, LLC 4.1%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Janus Henderson Group Ltd.
13F
Company
13F
11%
$157,089,660
11,125,330 shares
31 Dec 2023
RTW INVESTMENTS, LP
13F
Company
13F
7%
$98,104,602
6,947,918 shares
31 Dec 2023
Polar Capital Holdings Plc
13F
Company
13F
6.8%
$95,335,162
6,751,782 shares
31 Dec 2023
Jeffrey L. Gendell
13F
Individual
13F
5.7%
$79,288,742
5,615,350 shares
31 Dec 2023
Vivo Capital, LLC
13F
Company
13F
4.1%
$57,841,563
4,096,428 shares
31 Dec 2023
WEALTH EFFECTS LLC
13F
Company
13F
2.4%
$34,118,517
2,416,326 shares
31 Dec 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
118
Shares
67,722,532
Rows available
118
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2024 vs Q4 2025 Across Filers

Q4 2025 holders
2
Q1 2024 holders
118
Holder diff
116
Investor Q4 2025 Shares Q1 2024 Shares Share Diff Share Chg % Q4 2025 value Q1 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .